Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Markets & Finance

ST Robinson Humphrey Cuts Mentor Rating

ST Robinson Humphrey lowered its investment rating on Mentor Corp. (MNT) to hold from buy.

Analyst Ryan Rauch says that based on recent channel checks, Mentor's and Inamed's (IMDC) breast implant sales growth has slightly decelerated in the second quarter. He lowers Mentor's $50 million second-quarter breast implant estimate to $48.8 million, and Inamed's to $47.4 million. Also, he continues to be concerned over Mentor's penile implant sales growth as competitive impotency drug treatments continue to gain traction and will likely weaken this very profitable business unit. Rauch notes Mentor has been a strong performer, but while he applauds its recent execution and financial performance, he believes the risk/reward scenario is now less favorable.

blog comments powered by Disqus